Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results

Category Primary study
JournalANNALS OF ONCOLOGY
Year 2016
This article has no abstract
Epistemonikos ID: 2d0d21e52c50499e69f51387c815432c9875c77c
First added on: Feb 08, 2025